Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

J&J, following in Sanofi's footsteps, tasks i2o with oral delivery of large molecules
Fierce Pharma
Thu, 10/13/22 - 11:50 pm
Tags:
i20 Therapeutics, Sanofi, JNJ, large molecule drugs
Dupixent Shows Promise as First Treatment for Childhood EoE
BioSpace
Wed, 10/12/22 - 10:33 am
Tags:
Dupixent, Sanofi, Regeneron, pediatric, clinical trials, eosinophilic esophagitis
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
Tags:
biopharma stocks, AbbVie, Alnylam, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eisai, Eli Lilly, GSK, Intellia Therapeutics, Regeneron, Roche, Sanofi, Sarepta Therapeutics
Anticipating FDA Yes, Provention Inks Co-Promotion Deal with Sanofi for T1D Drug
BioSpace
Thu, 10/6/22 - 07:07 pm
Tags:
Provention Bio, Sanofi, type 1 diabetes, teplizumab
Sanofi, miRecule Ink Muscular Dystrophy Research Deal Worth up to $430M
BioSpace
Tue, 10/4/22 - 11:43 pm
Tags:
Sanofi, miRecule, myotonic muscular dystrophy
Sanofi licenses a preclinical genetic disease drug from an unknown biotech spun out of the NIH
Endpoints
Tue, 10/4/22 - 10:47 am
Tags:
Sanofi, antibody-RNA conjugate, miRecule, FSHD
FDA approves Sanofi and Regeneron’s Dupixent to treat prurigo nodularis
Pharmaceutical Business Review
Thu, 09/29/22 - 10:05 am
Tags:
Sanofi, Regeneron, Dupixent, prurigo nodularis, FDA
Sanofi and Jennifer Doudna-Founded Scribe ink $1B CRISPR cell therapy deal
Pharma Live
Tue, 09/27/22 - 10:23 am
Tags:
Sanofi, Scribe Therapeutics, CRISPR, Jennifer Doudna, gene editing
Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case
Fierce Pharma
Thu, 09/22/22 - 11:14 pm
Tags:
Amgen, patents, Supreme Court, Repatha, Sanofi, Regeneron
Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms
Fierce Pharma
Fri, 09/16/22 - 10:54 am
Tags:
Sanofi, AstraZeneca, Pfizer, GSK, nirsevimab, Beyfortus, RSV
Sanofi’s asthma therapy shows consistent safety profile in Phase III trial
Clinical Trials Arena
Tue, 09/6/22 - 05:06 pm
Tags:
Sanofi, Dupixent, pediatric, clinical trials, severe asthma, asthma
Medtech takes on pain
EP Vantage
Tue, 09/6/22 - 10:58 am
Tags:
Medtech, pain, devices, Abbott Labs, Medtronic, Sanofi, Redo Neurosystems, Boston Scientific
Sanofi's rare disease drug Xenpozyme scores FDA approval after nods in Japan and Europe
Fierce Pharma
Wed, 08/31/22 - 10:23 pm
Tags:
Sanofi, Xenpozyme, Niemann-Pick disease, FDA
Former Kadmon consultant pleads guilty to insider trading ahead of Sanofi buyout
Fierce Pharma
Wed, 08/24/22 - 10:42 am
Tags:
Sanofi, Kadmon, insider trading, legal, DOJ
As Sanofi's SERD falls, Menarini’s advances with EU review
Fierce Biotech
Fri, 08/19/22 - 10:42 am
Tags:
Sanofi, Menarini, Europe, SERD, breast cancer, elacstrant
Sanofi signs $1.2B pact with Atomwise in latest high-value AI drug discovery deal
Fierce Biotech
Wed, 08/17/22 - 12:19 pm
Tags:
Sanofi, artificial intelligence, drug discovery, biobucks, R&D, Atomwise
Sanofi scraps oral SERD strategy after 2nd failure in breast cancer
Fierce Biotech
Wed, 08/17/22 - 10:50 am
Tags:
Sanofi, SERD, breast cancer, clinical trials
Market reaction to Sanofi's upcoming litigation over Zantac is 'overblown,' analysts say
Fierce Pharma
Thu, 08/11/22 - 12:19 pm
Tags:
Sanofi, legal, Zantac
Absci lays off staff as it looks to reorganize amid stock falloff, bear market
Endpoints
Wed, 08/10/22 - 10:39 am
Tags:
Absci, Sanofi, layoffs
Looking east, Sanofi pens 'pioneering' cancer drug partnership with China's Innovent
Fierce Biotech
Fri, 08/5/22 - 10:38 am
Tags:
Sanofi, China, oncology, cancer, Innovent

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.